HomeNAV • CVE
add
Navco Pharmaceuticals Inc
Nakaraang pagsara
$0.010
Sakop ng taon
$0.0050 - $0.12
Market cap
570.70K CAD
Average na Volume
13.48K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Mga balita tungkol sa merkado
Investor's Business Daily
4 oras ang nakalipas
Market Focus Still On Tariffs; Tesla Leads Key Earnings
1.33%
0.92%
0.070%
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 7.10K | -97.31% |
Net na kita | -10.44K | 96.16% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | 8.44K | 103.34% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.38K | -98.27% |
Kabuuang asset | 56.27K | -90.73% |
Kabuuang sagutin | 923.46K | 16.69% |
Kabuuang equity | -867.20K | — |
Natitirang share | 57.07M | — |
Presyo para makapag-book | -0.50 | — |
Return on assets | -27.01% | — |
Return on capital | 2.27% | — |
Cash Flow
Net change in cash
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -10.44K | 96.16% |
Cash mula sa mga operasyon | -977.00 | 99.34% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | -4.99K | 19.17% |
Net change in cash | -5.97K | 96.15% |
Malayang cash flow | -29.08K | 95.05% |
Tungkol
Headquarters
Website
